2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
9
Colorectal Neoplasms
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Colonic Neoplasms
5
Rectal Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Wilms Tumor
2
Urogenital Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Syndromes, Hereditary
2
Neoplasms, Unknown Primary
2
Neoplasm Metastasis
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Leukemia
2
Kidney Neoplasms
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Glioma
2
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Irinotecan
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Taxes
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
Genetic Testing
×
Clear all
NCT06574620
2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA
Recruiting
200 enrolled